{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:15:03Z","timestamp":1791303303359,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T00:00:00Z","timestamp":1581379200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T00:00:00Z","timestamp":1581379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Science and Technology of Jilin Province, Jilin Province Key Laboratory","award":["3D517K363429"],"award-info":[{"award-number":["3D517K363429"]}]},{"name":"Youth Program of National Natural Science Foundation of China","award":["3A4197642429"],"award-info":[{"award-number":["3A4197642429"]}]},{"name":"The Role and Molecular Mechanism of EMT in the Resistance of ROS1-positive Lung Cancer","award":["20180101014JC"],"award-info":[{"award-number":["20180101014JC"]}]},{"name":"The Role and Molecular Mechanism of EMT in the Resistance of ROS1-positive Lung Cancer","award":["3D518PS23429"],"award-info":[{"award-number":["3D518PS23429"]}]},{"name":"Jilin Province Department of Finance Project","award":["3D5197398429"],"award-info":[{"award-number":["3D5197398429"]}]},{"name":"Jilin Province Department of Finance Project","award":["3D5197464429"],"award-info":[{"award-number":["3D5197464429"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1245\/s10434-020-08241-y","type":"journal-article","created":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T21:03:41Z","timestamp":1581455021000},"page":"3052-3063","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Clinicopathologic Features and Genetic Alterations in Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma of the Lung: Long-Term Follow-Up Study of 121 Asian Patients"],"prefix":"10.1245","volume":"27","author":[{"given":"Meng","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shili","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanqing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,11]]},"reference":[{"key":"8241_CR1","volume-title":"WHO classification of tumours of the lung, pleura, thymus and heart","author":"WD Travis","year":"2015","unstructured":"Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. WHO classification of tumours of the lung, pleura, thymus and heart, fourth edition. Lyon: IARC Press, 2015.","edition":"4"},{"key":"8241_CR2","doi-asserted-by":"crossref","unstructured":"Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer\/American Thoracic Society\/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6:244\u201385.","DOI":"10.1097\/JTO.0b013e318206a221"},{"key":"8241_CR3","doi-asserted-by":"crossref","unstructured":"Gu J, Lu C, Guo J, et al. Prognostic significance of the IASLC\/ATS\/ERS classification in Chinese patients\u2014A single institution retrospective study of 292 lung adenocarcinomas. J Surg Oncol. 2013;107:474\u201380.","DOI":"10.1002\/jso.23259"},{"key":"8241_CR4","doi-asserted-by":"crossref","unstructured":"Kadota K, Villena-Vargas J, Yoshizawa A, et al. Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease. Am J Surg Pathol. 2014;38:448\u201360.","DOI":"10.1097\/PAS.0000000000000134"},{"key":"8241_CR5","doi-asserted-by":"crossref","unstructured":"Kato F, Hamasaki M, Miyake Y, Iwasaki A, Iwasaki H, Nabeshima K. Clinicopathological characteristics of subcentimeter adenocarcinomas of the lung. Lung Cancer. 2012;77:495\u2013500.","DOI":"10.1016\/j.lungcan.2012.05.109"},{"key":"8241_CR6","doi-asserted-by":"crossref","unstructured":"Murakawa T, Konoeda C, Ito T, et al. The ground glass opacity component can be eliminated from the T-factor assessment of lung adenocarcinoma. Eur J Cardiothorac Surg. 2013;43:925\u201332.","DOI":"10.1093\/ejcts\/ezs467"},{"key":"8241_CR7","doi-asserted-by":"crossref","unstructured":"Nakagiri T, Sawabata N, Morii E, et al. Evaluation of the new IASLC\/ATS\/ERS proposed classification of adenocarcinoma based on lepidic pattern in patients with pathological stage IA pulmonary adenocarcinoma. Gen Thorac Cardiovasc Surg. 2014;62:671\u20137.","DOI":"10.1007\/s11748-014-0429-3"},{"key":"8241_CR8","doi-asserted-by":"crossref","unstructured":"Russell PA, Wainer Z, Wright GM, Daniels M, Conron M, Williams RA. Does lung adenocarcinoma subtype predict patient survival? A clinicopathologic study based on the new International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society international multidisciplinary lung adenocarcinoma classification. J Thorac Oncol. 2011;6:1496\u2013504.","DOI":"10.1097\/JTO.0b013e318221f701"},{"key":"8241_CR9","doi-asserted-by":"crossref","unstructured":"Woo T, Okudela K, Mitsui H, et al. Prognostic value of the IASLC\/ATS\/ERS classification of lung adenocarcinoma in stage I disease of Japanese cases. Pathol Int. 2012;62:785\u201391.","DOI":"10.1111\/pin.12016"},{"key":"8241_CR10","doi-asserted-by":"crossref","unstructured":"Yanagawa N, Shiono S, Abiko M, Ogata SY, Sato T, Tamura G. New IASLC\/ATS\/ERS classification and invasive tumor size are predictive of disease recurrence in stage I lung adenocarcinoma. J Thorac Oncol. 2013;8:612\u20138.","DOI":"10.1097\/JTO.0b013e318287c3eb"},{"key":"8241_CR11","doi-asserted-by":"crossref","unstructured":"Yoshizawa A, Motoi N, Riely GJ, et al. Impact of proposed IASLC\/ATS\/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol. 2011;24:653\u201364.","DOI":"10.1038\/modpathol.2010.232"},{"key":"8241_CR12","doi-asserted-by":"crossref","unstructured":"Yoshizawa A, Sumiyoshi S, Sonobe M, et al. Validation of the IASLC\/ATS\/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients. J Thorac Oncol. 2013;8:52\u201361.","DOI":"10.1097\/JTO.0b013e3182769aa8"},{"key":"8241_CR13","doi-asserted-by":"crossref","unstructured":"Zhang J, Wu J, Tan Q, Zhu L, Gao W. Why do pathological stage IA lung adenocarcinomas vary from prognosis? A clinicopathologic study of 176 patients with pathological stage IA lung adenocarcinoma based on the IASLC\/ATS\/ERS classification. J Thorac Oncol. 2013;8:1196\u2013202.","DOI":"10.1097\/JTO.0b013e31829f09a7"},{"key":"8241_CR14","doi-asserted-by":"crossref","unstructured":"Murakami S, Ito H, Tsubokawa N, et al. Prognostic value of the new IASLC\/ATS\/ERS classification of clinical stage IA lung adenocarcinoma. Lung Cancer. 2015;90:199\u2013204.","DOI":"10.1016\/j.lungcan.2015.06.022"},{"key":"8241_CR15","doi-asserted-by":"crossref","unstructured":"Si MJ, Tao XF, Du GY, et al. Thin-section computed tomography-histopathologic comparisons of pulmonary focal interstitial fibrosis, atypical adenomatous hyperplasia, adenocarcinoma in situ, and minimally invasive adenocarcinoma with pure ground-glass opacity. Eur J Radiol. 2016;85:1708\u201315.","DOI":"10.1016\/j.ejrad.2016.07.012"},{"key":"8241_CR16","doi-asserted-by":"crossref","unstructured":"Hansell DM, Bankier AA, MacMahon H, McLoud TC, Muller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology. 2008;246:697\u2013722.","DOI":"10.1148\/radiol.2462070712"},{"key":"8241_CR17","doi-asserted-by":"crossref","unstructured":"Yoo SB, Chung JH, Lee HJ, Lee CT, Jheon S, Sung SW. Epidermal growth factor receptor mutation and p53 overexpression during the multistage progression of small adenocarcinoma of the lung. J Thorac Oncol. 2010;5:964\u20139.","DOI":"10.1097\/JTO.0b013e3181dd15c0"},{"key":"8241_CR18","doi-asserted-by":"crossref","unstructured":"Sun PL, Jin Y, Kim H, et al. Survivin expression is an independent poor prognostic marker in lung adenocarcinoma but not in squamous cell carcinoma. Virchows Arch. 2013;463:427\u201336.","DOI":"10.1007\/s00428-013-1462-9"},{"key":"8241_CR19","doi-asserted-by":"crossref","unstructured":"Jin Y, Sun PL, Park SY, et al. Frequent aerogenous spread with decreased E-cadherin expression of ROS1-rearranged lung cancer predicts poor disease-free survival. Lung Cancer. 2015;89:343\u20139.","DOI":"10.1016\/j.lungcan.2015.06.012"},{"key":"8241_CR20","doi-asserted-by":"crossref","unstructured":"Kim H, Yoo SB, Choe JY, et al. Detection of ALK gene rearrangement in non-small cell lung cancer: a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression. J Thorac Oncol. 2011;6:1359\u201366.","DOI":"10.1097\/JTO.0b013e31821cfc73"},{"key":"8241_CR21","doi-asserted-by":"crossref","unstructured":"Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1975;70:606\u201312.","DOI":"10.1016\/S0022-5223(19)40289-4"},{"key":"8241_CR22","doi-asserted-by":"crossref","unstructured":"Ishida H, Shimizu Y, Sakaguchi H, et al. Distinctive clinicopathological features of adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung: a retrospective study. Lung Cancer. 2019;129:16\u201321.","DOI":"10.1016\/j.lungcan.2018.12.020"},{"key":"8241_CR23","doi-asserted-by":"crossref","unstructured":"Wang X, Wang L, Zhang W, Zhao H, Li F. Can we differentiate minimally invasive adenocarcinoma and non-invasive neoplasms based on high-resolution computed tomography features of pure ground glass nodules? PLoS One. 2017;12:e0180502.","DOI":"10.1371\/journal.pone.0180502"},{"key":"8241_CR24","doi-asserted-by":"crossref","unstructured":"Imai K, Minamiya Y, Goto A, et al. Bronchioloalveolar invasion in non-small cell lung cancer is associated with expression of transforming growth factor-beta1. World J Surg Oncol. 2013;11:113.","DOI":"10.1186\/1477-7819-11-113"},{"key":"8241_CR25","doi-asserted-by":"crossref","unstructured":"Inamura K. Clinicopathological characteristics and mutations driving development of early lung adenocarcinoma: tumor initiation and progression. Int J Mol Sci. 2018;19:1259.","DOI":"10.3390\/ijms19041259"},{"key":"8241_CR26","doi-asserted-by":"crossref","unstructured":"Nakamura H, Koizumi H, Kimura H, Marushima H, Saji H, Takagi M. Epidermal growth factor receptor mutations in adenocarcinoma in situ and minimally invasive adenocarcinoma detected using mutation-specific monoclonal antibodies. Lung Cancer. 2016;99:143\u20137.","DOI":"10.1016\/j.lungcan.2016.07.009"},{"key":"8241_CR27","doi-asserted-by":"crossref","unstructured":"Sakamoto H, Shimizu J, Horio Y, et al. Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas. J Pathol. 2007;212:287\u201394.","DOI":"10.1002\/path.2165"},{"key":"8241_CR28","doi-asserted-by":"crossref","unstructured":"Yu Y, Ding Z, Zhu L, Teng H, Lu S. Frequencies of ALK rearrangements in lung adenocarcinoma subtypes: a study of 2299 Chinese cases. SpringerPlus. 2016;5:894.","DOI":"10.1186\/s40064-016-2607-5"},{"key":"8241_CR29","doi-asserted-by":"crossref","unstructured":"Tsuta K, Kawago M, Inoue E, et al. The utility of the proposed IASLC\/ATS\/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations. Lung Cancer. 2013;81:371\u20136.","DOI":"10.1016\/j.lungcan.2013.06.012"},{"key":"8241_CR30","doi-asserted-by":"crossref","unstructured":"Xu X, Li N, Zhao R, Zhu L, Shao J, Zhang J. Targeted next-generation sequencing for analyzing the genetic alterations in atypical adenomatous hyperplasia and adenocarcinoma in situ. 2017;143:2447\u201353.","DOI":"10.1007\/s00432-017-2500-9"},{"key":"8241_CR31","doi-asserted-by":"crossref","unstructured":"Kobayashi Y, Mitsudomi T, Sakao Y, Yatabe Y. Genetic features of pulmonary adenocarcinoma presenting with ground-glass nodules: the differences between nodules with and without growth. Ann Oncol. 2015;26:156\u201361.","DOI":"10.1093\/annonc\/mdu505"},{"key":"8241_CR32","doi-asserted-by":"crossref","unstructured":"Jin Y, Sun PL, Kim H, et al. ROS1 gene rearrangement and copy number gain in non-small cell lung cancer. Virchows Arch. 2015;466:45\u201352.","DOI":"10.1007\/s00428-014-1679-2"},{"key":"8241_CR33","doi-asserted-by":"crossref","unstructured":"Tominaga M, Sueoka N, Irie K, et al. Detection and discrimination of preneoplastic and early stages of lung adenocarcinoma using hnRNP B1 combined with the cell cycle-related markers p16, cyclin D1, and Ki-67. Lung Cancer. 2003;40:45\u201353.","DOI":"10.1016\/S0169-5002(02)00529-9"},{"key":"8241_CR34","doi-asserted-by":"crossref","unstructured":"Tsubokawa N, Mimae T, Sasada S, et al. Negative prognostic influence of micropapillary pattern in stage IA lung adenocarcinoma. Eur J Cardiothorac Surg. 2016;49:293\u20139.","DOI":"10.1093\/ejcts\/ezv058"},{"key":"8241_CR35","doi-asserted-by":"crossref","unstructured":"Wang L, Jiang W, Zhan C, et al. Lymph node metastasis in clinical stage IA peripheral lung cancer. Lung Cancer. 2015;90:41\u20136.","DOI":"10.1016\/j.lungcan.2015.07.003"},{"key":"8241_CR36","doi-asserted-by":"crossref","unstructured":"Zhang Y, Sun Y, Xiang J, Zhang Y, Hu H, Chen H. A clinicopathologic prediction model for postoperative recurrence in stage Ia non-small cell lung cancer. J Thorac Cardiovasc Surg. 2014;148:1193\u20139.","DOI":"10.1016\/j.jtcvs.2014.02.064"},{"key":"8241_CR37","doi-asserted-by":"crossref","unstructured":"Zhao W, Wang H, Xie J, Tian B. A clinicopathological study of small lung adenocarcinoma 1\u00a0cm or less in size: emphasis on histological subtypes associated with lymph node metastasis and recurrence. Int J Surg Pathol. 2018;26:4\u201311.","DOI":"10.1177\/1066896917721649"},{"key":"8241_CR38","first-page":"e57","volume":"201617","author":"M Behera","year":"2011","unstructured":"Behera M, Owonikoko TK, Gal AA, et al. Lung adenocarcinoma staging using the 2011 IASLC\/ATS\/ERS classification: a pooled analysis of adenocarcinoma in situ and minimally invasive adenocarcinoma. Clin Lung Cancer. 2016;17:e57\u201364.","journal-title":"Clin Lung Cancer."},{"key":"8241_CR39","doi-asserted-by":"crossref","unstructured":"Xu L, Tavora F, Battafarano R, Burke A. Adenocarcinomas with prominent lepidic spread: retrospective review applying new classification of the American Thoracic Society. Am J Surg Pathol. 2012;36:273\u201382.","DOI":"10.1097\/PAS.0b013e31823b3eeb"},{"key":"8241_CR40","doi-asserted-by":"crossref","unstructured":"Tsutani Y, Miyata Y, Mimae T, et al. The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma. J Thorac Cardiovasc Surg. 2013;146:580\u20135.","DOI":"10.1016\/j.jtcvs.2013.04.032"},{"key":"8241_CR41","doi-asserted-by":"crossref","unstructured":"Moon Y, Sung SW, Lee KY, Sim SB, Park JK. Pure ground-glass opacity on chest computed tomography: predictive factors for invasive adenocarcinoma. J Thorac Dis. 2016;8:1561\u201370.","DOI":"10.21037\/jtd.2016.06.34"},{"key":"8241_CR42","doi-asserted-by":"crossref","unstructured":"Cho S, Yang H, Kim K, Jheon S. Pathology and prognosis of persistent stable pure ground-glass opacity nodules after surgical resection. Ann Thorac Surg. 2013;96:1190\u20135.","DOI":"10.1016\/j.athoracsur.2013.05.062"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08241-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-020-08241-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08241-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T06:27:31Z","timestamp":1612938451000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-020-08241-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,11]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["8241"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-08241-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,11]]},"assertion":[{"value":"10 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}